Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

被引：23

作者：

Takigawa, N. ^{[1
]}

Kiura, K.

Segawa, Y.

Watanabe, Y.

Kamei, H.

Moritaka, T.

Shibayama, T.

Ueoka, H.

Gemba, K.

Yonei, T.

Tabata, M.

Shinkai, T.

Hiraki, S.

Takemoto, M.

Kanazawa, S.

Matsuo, K.

Tanimoto, M.

机构：

[1] Okayama Univ, Dept Hematol Oncol & Resp Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan

[2] Okayama Univ Hosp, Okayama 7008558, Japan

[3] Natl Hosp Org, Shikoku Canc Ctr, Dept Med & Thorac Oncol, Matsuyama, Ehime 7910288, Japan

[4] Okayama Red Cross Hosp, Dept Internal Med, Okayama 7008607, Japan

[5] Sumitomo Besshi Gen Hosp, Dept Internal Med, Niihama 7928543, Japan

[6] Ehime Prefectural Cent Hosp, Dept Pulm Med, Matsuyama, Ehime 7900024, Japan

[7] Natl Hosp Org, Minami Okayama Med Ctr, Dept Pulm Med, Tsukuba 7010304, Japan

[8] Sanyo Hosp, Natl Hosp Org, Dept Med, Ube, Yamaguchi 7550241, Japan

[9] Okayama Rosai Hosp, Dept Pulm Med, Okayama 7028055, Japan

[10] Okayama Med Ctr, Dept Pulm Med, Okayama 7011192, Japan

[11] Okayama Univ, Dept Radiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan

[12] Aichi Canc Ctr, Inst Res, Dept Epidemiol & Prevent, Nagoya, Aichi 4948681, Japan

来源：

BRITISH JOURNAL OF CANCER | 2006年 / 95卷 / 09期

关键词：

non-small-cell lung cancer; chemotherapy; radiotherapy; second primary cancer;

D O I：

10.1038/sj.bjc.6603422

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median followup of 8.9 years. The incidence of SPC was 2.4 per 100 patient- years (95% confidence interval: 1.0 - 4.9).

引用

页码：1142 / 1144

页数：3

共 13 条

[1] Mechanisms of therapy-related carcinogenesis [J].

Allan, JM ;

Lois, BT .

NATURE REVIEWS CANCER, 2005, 5 (12) :943-955

[2] Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC):: A meta-analysis of individual data from 1764 patients [J].

Aupérin, A ;

Le Péchoux, C ;

Pignon, JP ;

Koning, C ;

Jeremic, B ;

Clamon, G ;

Einhorn, L ;

Ball, D ;

Trovo, MG ;

Groen, HJM ;

Bonner, JA ;

Le Chevalier, T ;

Arriagada, R .

ANNALS OF ONCOLOGY, 2006, 17 (03) :473-483

[3] Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? [J].

Carolan, H ;

Sun, AY ;

Bezjak, A ;

Yi, QL ;

Payne, D ;

Kane, G ;

Waldron, J ;

Leighl, N ;

Feld, R ;

Burkes, R ;

Keshavjee, S ;

Shepherd, F .

LUNG CANCER, 2005, 49 (01) :109-115

[4] Second primary tumors involving non-small cell lung cancer - Prevalence and its influence on survival [J].

Duchateau, CSJ ;

Stokkel, MPM .

CHEST, 2005, 127 (04) :1152-1158

[5] Time from treatment to subsequent diagnosis of brain, metastases in stage III non-small-cell lung cancer: A retrospective review by the southwest oncology group [J].

Gaspar, LE ;

Chansky, K ;

Albain, KS ;

Vallieres, E ;

Rusch, V ;

Crowley, JJ ;

Livingston, RB ;

Gandara, DR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2955-2961

[6] RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].

HOLMES, CE ;

RUCKDESCHEL, JC ;

JOHNSTON, M ;

THOMAS, PA ;

DESLAURIERS, J ;

GROVER, FL ;

HILL, LD ;

FELD, R ;

GINSBERG, RJ ;

MOUNTAIN, CF ;

DZUIBAN, S ;

KIELY, M ;

MCKNEALLY, MF ;

MOORES, DWO ;

RAMNES, C ;

WAGNER, H ;

BUNN, P ;

CHU, H ;

DIENHART, D ;

HAZUKA, M ;

KINZIE, J ;

SORENSEN, J ;

VANCE, V ;

BRAUN, T ;

HOPEMAN, A ;

KANE, M ;

RUSS, P ;

WHITMAN, GJR ;

FALL, SM ;

HANSEN, DP ;

HENDERSON, RH ;

MONCRIEF, CL ;

PAULING, F ;

SIMS, J ;

TELL, D ;

WISELYCARR, S ;

ABERNATHY, CM ;

CLARK, DA ;

MCCROSKEY, B ;

MOORE, G ;

MOORE, F ;

MYERS, A ;

WHITE, M ;

BROOKS, RJ ;

BULL, M ;

JOHNSON, FB ;

NEIMYR, M ;

PAQUETTE, FR ;

SACCOMANNO, G ;

LAD, T .

ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622

[7] Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone [J].

Jeremic, B ;

Shibamoto, Y ;

Acimovic, L ;

Nikolic, N ;

Dagovic, A ;

Aleksandrovic, J ;

Radosavljevic-Asic, G .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1056-1063

[8] Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy [J].

Kawaguchi, T ;

Matsumura, A ;

Iuchi, K ;

Ishikawa, S ;

Maeda, H ;

Fukai, S ;

Komatsu, H ;

Kawahara, M .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) :7-11

[9] Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer [J].

Kiura, K ;

Ueoka, H ;

Segawa, Y ;

Tabata, M ;

Kamei, H ;

Takigawa, N ;

Hiraki, S ;

Watanabe, Y ;

Bessho, A ;

Eguchi, K ;

Okimoto, N ;

Harita, S ;

Takemoto, M ;

Hiraki, Y ;

Harada, M ;

Tanimoto, M .

BRITISH JOURNAL OF CANCER, 2003, 89 (05) :795-802

[10]

MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606

← 1 2 →